
US children are much more likely to die than kids in similar countries, study finds
Chronic diseasesFacebookTweetLink
Follow
American children's health has declined profoundly over the past few decades, a new study shows, and the issues are so serious that children in the US are dying at a much higher rate than those in similar high-income countries.
What's particularly frustrating is that the bulk of the health problems are avoidable, said Dr. Chris Forrest, co-author of the study published Monday in the journal JAMA. There isn't a genetic defect unique to American children and it's not about socioeconomics within the United States, he said: The results were applicable to the total pediatric population.
'I think we all should be disturbed by this,' said Forrest, a professor of pediatrics at Children's Hospital of Philadelphia and director of the Applied Clinical Research Center. 'Kids in this country are really suffering.'
From 2007 to 2022, children ages 1 to 19 were 1.8 times more likely to die than children in other high-income countries, the study found. The biggest disparities were in deaths from gun violence and traffic accidents; kids in the US were 15 times more likely than their counterparts in other countries to die by firearms and more than twice as likely to die in motor vehicle crashes.
But US children are also sicker because of chronic conditions, Forrest said, and that's a newer phenomenon. In the '90s, when he started taking care of children, he said, he hardly ever saw one with a chronic condition. Today, nearly half of children are getting medical care for a chronic health problem, the study says.
The researchers, who analyzed hundreds of millions of health records from five nationally representative surveys and electronic health records from 10 pediatric health systems, found that a child in 2023 was 15% to 20% more likely to have a chronic condition than a child in 2011.
Asthma was the one chronic condition for which rates improved in the studied time period, but it was an outlier. Rates of mental health problems such as depression, anxiety and loneliness increased, as did rates of autism, behavioral conduct problems, developmental delays, speech language disorders and attention-deficit hyperactivity disorders.
Rates of physical issues also increased significantly, including problems with obesity, difficulties with limitations in activity, problems with sleeping and early menstruation. A period before age 12 is associated with immediate health problems including type 2 diabetes, but in the long term, it may also raise the risk of heart and blood pressure problems, studies show.
Chronic conditions were the focus of a recent federal government report from the Make America Healthy Again Commission that said chronic disease had made children 'the sickest generation in American history.' That report blamed ultraprocessed food, exposure to chemicals in the environment, pervasive technology use and the overprescription of medicine.
The new study doesn't pinpoint what's driving the increase in chronic conditions, but Forrest doesn't believe it's just what's on the MAHA list. Rather, he believes the nation's entire approach toward caring for children needs to change.
'Our kids are being raised in a very toxic environment, and it's not just the chemicals. It's not just the food and the iPhones. It's a much broader. It's much deeper. It's what we call the developmental ecosystem, and it makes it very challenging to change it,' Forrest said. 'That's a hard answer for people who want a pithy message that tells them how to fix the issues. It's about where they're growing up, where they're going to school, they're playing, where their families live, their neighborhoods, and it's not just one population. It's the whole nation that needs help.'
In the 1960s, children in the US were dying at about the same rate as in countries with similar incomes, but that started to change in the 1970s. The US now has about 54 excess child deaths per day compared with 18 other wealthy countries.
'This means the same kid born in this country is much more likely to die than if they were born in Germany or Denmark. Why are we allowing this to happen?' Forrest asked.
In an editorial that published alongside the study, pediatricians from Virginia and Washington wrote that there's reason to worry the health of US children will continue to fall behind, and political winds are shifting in the wrong direction.
'While the administration's Make America Healthy Again movement is drawing welcome attention to chronic diseases and important root causes such as ultra-processed foods, it is pursuing other policies that will work against the health interests of children,' they wrote, noting massive budget cuts at the US Department of Health and Human Services, including injury prevention, cancelled funding for safe sleep programs, Medicaid reductions, shrinking mental health funding and new initiatives that fuel vaccine hesitancy among parents.
The study found that from 2007 to 2022, babies in the US were 1.78 times more likely to die than children in 18 other high-income nations. The biggest disparities in deaths were from prematurity and sudden, unexpected infant death, which is accidental suffocation and strangulation in bed and other deaths from unknown causes.
But it's not just children who are at risk, Forrest said. 'Kids are not getting great start in life because women are also suffering in this country.'
Maternity deserts, where pregnant people don't have easy access to a doctor, have become a growing problem. According to the March of Dimes, about 35% of counties in the US are maternity deserts, a number likely to grow as states pass stricter abortion laws, driving doctors toward states where it's less complicated to provide care. In 2020-22, there were an excess of over 10,000 preterm births among people living in maternity care deserts or limited-access counties, the group says.
Dr. Colleen Kraft, a pediatrician at Children's Hospital Los Angeles who did not work on the research, said the study provides good data on broad problems.
'Nothing here surprises me at all,' said Kraft, former president of the American Academy of Pediatrics, who wasn't involved in the new research.
Over 35 years of practice, she has seen the change in her own patients. At the beginning, she treated mostly infectious disease, but vaccines for conditions like meningococcal disease changed that. Now, she fears that anti-vaccine sentiment could erode much of that progress.
She also treats a lot more children now for chronic conditions that the community can help prevent, she said.
For example, schools could restrict mobile phones so kids interact more, easing problems with loneliness, anxiety and depression. Families can implement a media plan where all devices are plugged into a central location – not a bedroom – so children can get more sleep. Parents can also encourage kids to play outside and engage in more unstructured time to be social and develop their imaginations.
'There are some very common-sense things families can do,' Kraft said.
To see major improvement in childhood health in the US, Forrest believes the country will need to undergo a major transformation. In other countries, for example, day care workers are professionals who get paid a living wage, so kids get quality care. Parents also get more time off when they have a child.
'It's time to rethink how we treat kids and how we're supporting families,' Forrest said. 'Children in our nation our like the proverbial canary in the coal mine. When their health is deteriorating, that means the foundation of our nation is also deteriorating.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison
Exhale Wellness earns top spot for best Delta 9 gummies in 2025, recognized for quality, transparency, and customer satisfaction by Onpattison. Charlotte, NC, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onpattison has named Exhale Wellness the #1 Delta 9 gummy brand in its 2025 rankings, citing the company's emphasis on clean formulations, product transparency, and third-party testing. The annual list, compiled by the publication's wellness editorial team, highlighted 5 standout hemp-derived THC products that met high standards for safety, effectiveness, and consumer trust. Exhale Wellness's plant-based approach and commitment to rigorous quality control played a key role in securing the top spot for the brand. What Are Delta 9 Gummies? Delta 9 gummies are edible products containing Delta 9 tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis. When sourced from federally legal hemp and formulated within compliant THC limits (less than 0.3% Delta 9 THC), these gummies offer a controlled, predictable way to consume THC. In its 2025 ranking, Onpattison recognized brands that deliver not only efficacy but also transparency and consumer safety in their Delta 9 offerings, criteria that Exhale Wellness met with distinction. Delta 9 THC Gummies: The Flagship Behind the #1 RankingAt the center of Onpattison's ranking is Exhale Wellness's Delta-9 Bottle Caps, the company's flagship gummy product. Editors cited the product's balanced potency, full-spectrum formulation, and transparency in testing as key reasons for awarding Exhale the top spot. Each bottle contains 450 mg of hemp-derived Delta 9 THC, formulated from full-spectrum hemp extract to preserve the natural cannabinoid and terpene profile. This approach contributes to what users often describe as a more rounded, longer-lasting experience compared to isolates. Bottle Caps were also recognized for their clean formulation, including vegan ingredients and naturally flavored profiles such as Cherry Cola, Lemon-Lime, and Orange. Exhale's use of U.S.-grown hemp and third-party lab testing ensures that each batch meets federal compliance standards outlined in the 2018 Farm Bill. In this context, Exhale's published Certificates of Analysis (COAs), available to consumers, were noted as a strong indicator of transparency and consumer trust. Additional Features That Contributed to the Best Ranking In naming Exhale Wellness the #1 Delta 9 thc gummy brand of 2025, Onpattison highlighted several distinguishing factors beyond formulation alone. One was consistency in potency, with each gummy delivering a reliable 15 mg of hemp-derived Delta 9 THC, an important element for responsible dosing and user experience. The product's clean, vegan formulation was also a factor in the ranking. Made with plant-based pectin, natural flavors, and free from artificial additives, Bottle Caps reflects growing consumer demand for health-conscious, non-GMO edibles. While the Bottle Caps line is relatively new, Onpattison noted Exhale's overall brand reputation for quality and transparency. Across its product offerings, Exhale has earned strong consumer reviews for consistency, ease of use, and customer service, qualities that helped set the brand apart in a competitive evaluation process. Why Exhale Wellness Was Chosen as Delta 9 Gummies? Exhale Wellness earned the top spot in Onpattison's 2025 Delta 9 thc gummy rankings due to its commitment to product integrity, transparency, and user trust. The evaluation highlighted several standout factors that contributed to the brand's placement: Transparent Sourcing and Lab TestingEach batch of Exhale's Delta 9 gummies is verified through third-party lab testing, with publicly available Certificates of Analysis (COAs) confirming cannabinoid content, potency, and product safety. This level of transparency was a key differentiator in the ranking process. Clean, Plant-Based FormulationsThe editorial team emphasized Exhale's use of organic, non-GMO ingredients and vegan-friendly formulations made without artificial additives. The use of pectin over gelatin reflects a thoughtful approach to ingredient sourcing. Established Brand ReputationWhile Bottle Caps is one of the newer products in Exhale's portfolio, the brand's track record of quality and responsiveness was cited as a contributing factor. Consistent consumer satisfaction across Exhale's broader product line reinforced its credibility. Balanced Potency and Full-Spectrum EffectThe magazine also acknowledged the company's use of full-spectrum hemp extract, which preserves a range of cannabinoids and terpenes for a more comprehensive user experience. This format, paired with clearly labeled dosing, supports a wide range of consumer preferences. Editorial Criteria That Set Exhale Wellness Apart In evaluating the best Delta 9 THC gummies for its 2025 ranking, Onpattison applied a broad set of criteria reflecting the current standards for product quality and consumer trust. Exhale Wellness met or exceeded expectations across the following key areas: Sourcing and Agricultural Standards Exhale uses hemp grown in the United States under regulated agricultural practices, minimizing exposure to pesticides, heavy metals, or synthetic additives. Domestic sourcing was a baseline requirement in the magazine's review process. Potency and Dose TransparencyEach gummy contains a clearly labeled 15 mg of Delta 9 THC. The publication highlighted brands that offer reliable, consistent dosing, a crucial element for consumers managing intake responsibly. Clean Ingredient Profile Formulations were evaluated for ingredient transparency. Exhale's plant-based, vegan gummies, made without artificial colorants or high-fructose corn syrup, were noted for addressing evolving consumer preferences. Third-Party Lab Testing and COA Access Brands without published lab results were excluded from consideration. Exhale's publicly accessible Certificates of Analysis (COAs) confirmed potency, cannabinoid breakdown, and absence of contaminants. Flavor and Product Consistency Taste and texture factored into the overall experience. Exhale's use of natural flavoring and consistent formulation across batches contributed positively to its assessment. Responsiveness Exhale's reputation for customer support, shipping reliability, and product consistency helped distinguish it in a crowded market. Editorial staff considered both consumer sentiment and company transparency during the review. Legal Compliance All selected brands were required to meet the 2018 Farm Bill threshold of 0.3% Delta 9 THC by dry weight. Exhale's compliance was verified through both internal documentation and third-party reports. Exhale Wellness's Delta 9 Gummies Availability Exhale Wellness's Delta 9 gummies, including the award-winning Bottle Caps line, are available for purchase through the company's official website. Each product listing includes detailed lab reports (COAs), ingredient information, and dosage specifications to support consumer transparency. All Exhale Wellness Delta 9 THC products comply with the 2018 Farm Bill, containing no more than 0.3% THC by dry weight. Products are available for shipment to states where hemp-derived Delta 9 THC is permitted, and all customers must be 21 years or older to purchase. Shipping practices adhere to federal and state-level compliance requirements. FAQs about Delta THC Gummies What is Delta 9 THC? Delta 9 tetrahydrocannabinol (THC) is the primary psychoactive compound found in cannabis. It interacts with the body's endocannabinoid system and is known for producing effects such as euphoria and relaxation. When derived from hemp and used within legal limits, it can be formulated into federally compliant wellness products. Are Exhale Wellness's Delta 9 Gummies Legal? Yes. Exhale Wellness's Delta 9 gummies are made from hemp-derived THC and contain no more than 0.3% Delta 9 THC by dry weight, in accordance with the 2018 Farm Bill. Federal legality does not guarantee state-level approval, so consumers are advised to check local laws before purchasing. What makes Exhale Wellness different from other Delta 9 gummy brands? Exhale Wellness was recognized by Onpattison for its product consistency, lab-tested transparency, and clean ingredient profile. The brand uses non-GMO, vegan-friendly formulations and publishes third-party Certificates of Analysis for every batch. How strong are the best Delta 9 Gummies from Exhale Wellness? Each gummy contains 15 mg of hemp-derived Delta 9 THC. This dosage format offers a balanced and consistent experience and is intended to support responsible use among both new and experienced consumers. Do Exhale Wellness's gummies ship nationwide? Exhale Wellness ships to U.S. states where hemp-derived Delta 9 THC products are legally permitted. While the products are federally legal, shipping availability is subject to state-specific regulations. How long do the effects last? The effects of hemp-derived Delta 9 gummies typically last between 6 and 9 hours, depending on individual factors such as body chemistry, metabolism, and tolerance. Onset time may be delayed due to digestion. How should Delta 9 THC be dosed? Dosing recommendations vary by user. For those new to Delta 9 THC, a lower dose (such as 2.5 to 5 mg) is generally suggested to gauge individual response. Gradual adjustment over time can help maintain a safe and comfortable experience. Conclusion Exhale Wellness's selection as the top Delta 9 gummy brand in Onpattison's 2025 rankings reflects the company's emphasis on ingredient transparency, consistent dosing, and third-party lab testing. The recognition highlights Exhale's approach to federally compliant hemp products at a time when consumer standards for quality and accountability in the wellness space are rising. For more information, visit CONTACT: Company Name: Exhale Wellness Phone Number: (323) 448-3810 Email: support@ Official Address: Charlotte, NC 28273, United StatesSign in to access your portfolio


Medscape
5 minutes ago
- Medscape
Cannabis Use Disorder Tied to Benign Salivary Tumors
TOPLINE: Cannabis use disorder (CUD) was associated with a greater than fivefold increased risk for benign tumors of major salivary glands compared to not having CUD, a new retrospective study showed. Additionally, the elevated risk persisted beyond 5 years of follow-up and particularly affected the parotid salivary gland. METHODOLOGY: As previous research showed a link between cigarette smoking and benign gland tumors, the current investigators wanted to assess whether CUD was also associated with these tumors. In this retrospective cohort study, they analyzed electronic medical records from 66 US-based healthcare organizations. Incidence of any benign major salivary gland tumor and parotid salivary gland tumor was compared between nearly 184,000 adults with a history of hospital outpatient visit and CUD and more than 6 million individuals without CUD between 2005 and 2025. Propensity score matching was applied to adjust for clinical characteristics, including age, race, ethnicity, tobacco use, nicotine use disorder, and a history of radiation. TAKEAWAY: The incidence of benign tumor of any major salivary gland and that of the parotid salivary gland was higher in the CUD group than in the non-CUD group (0.08 vs 0.02% and 0.05 vs 0.01%, respectively). Relative risk for any benign major salivary gland tumor was higher in the CUD vs non-CUD group at all timepoints between index event and outcome assessment (risk ratio [RR] for any time, 5.2; RR for 0-5 years, 4.3; RR for ≥ 5 years, 5.0). Relative risk for benign tumor of the parotid salivary gland was also increased after a diagnosis of CUD (RR for any time, 5.2; RR for 0-5 years, 4.9; RR for ≥ 5 years, 3.9). IN PRACTICE: 'The elevated relative risk of benign parotid tumors and the persistent association over time highlight potential site-specific outcomes of cannabis use,' the investigators wrote. 'Future prospective research with large samples and data on cannabis doing, method of use, and benign salivary gland neoplasm pathology is required to further assess and confirm this association,' they added. SOURCE: The study was led by Tyler J. Gallagher, MD, Keck School of Medicine, University of Southern California, Los Angeles. It was published online on July 17 in JAMA Otolaryngology-Head & Neck Surgery. LIMITATIONS: The study was constrained by the absence of cannabis dosage information and histologic data on benign salivary gland tumors and a limited long-term follow-up. DISCLOSURES: The investigators reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Forbes
36 minutes ago
- Forbes
Medical School Grads Avidly Pursuing Psychiatry Despite Or Maybe Spurred By Rise Of AI Mental Health Apps
In today's column, I examine the latest headline news that medical school grads are avidly pursuing psychiatry as their career pathway, which seems somewhat contradictory to ongoing pronouncements that AI is going to take over as a mental health advisor and usurp the role of human therapists. Why would sharp-as-nails med school grads opt toward a presumably dead-end occupational route? Let's talk about it. This analysis of AI breakthroughs is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here). AI And Mental Health Therapy As a quick background, I've been extensively covering and analyzing a myriad of facets regarding the advent of modern-era AI that produces mental health advice and performs AI-driven therapy. This rising use of AI has principally been spurred by the evolving advances and widespread adoption of generative AI. For a quick summary of some of my posted columns on this evolving topic, see the link here, which briefly recaps about forty of the over one hundred column postings that I've made on the subject. There is little doubt that this is a rapidly developing field and that there are tremendous upsides to be had, but at the same time, regrettably, hidden risks and outright gotchas come into these endeavors too. I frequently speak up about these pressing matters, including in an appearance last year on an episode of CBS's 60 Minutes, see the link here. If you are new to the topic of AI for mental health, you might want to consider reading my recent analysis of the field, which also recounts a highly innovative initiative at the Stanford University Department of Psychiatry and Behavioral Sciences called AI4MH; see the link here. Latest News Is Uplifting A recent news report noted that medical school graduates are increasingly pursuing psychiatry. In a posting entitled 'More Med School Grads Choose Psychiatry – Again' by Mark Moran, Psychiatric News, May 29, 2025, these key points were made (excerpts): The claimed overarching basis for this interest in psychiatry, as suggested in the last point, would be that we are daily bombarded with indications that mental health issues are becoming widespread. Thus, these younger generation grads are undoubtedly seeking to apply their acumen to solving this national and global dilemma. Good for them. One could also cynically observe that this also means that there ought to be a lot of business available for those grads. Namely, the rising demand for therapy will be strong and ensure a long-lasting livelihood for this chosen profession. Nothing is wrong with wanting to have a financially secure future. All seems glorious and upbeat. The AI Mental Health Takeover The hitch is this. There is an immense rise in the use of generative AI and large language models (LLMs) as a surrogate for seeking mental health guidance. Indeed, many predictions are that people often prefer AI since it easy to access on an anywhere anytime basis, it is super inexpensive if not free to use, it tends to be highly empathetic in appearance (see my discussion at the link here), and AI seems to be a kind of anonymous non-judgmental form of psychological analysis (this isn't the case but many falsely believe this to be true). All in all, the bottom line is that AI is predicted to gut the need for human therapists. Patients will angle toward using AI in lieu of seeing a mental health professional. Even if AI doesn't seem a suitable replacement from the perspective of the profession itself, clients are going to gravitate toward AI anyway. The alluring traits, as I've noted, are so compelling that it is hard to justify going toward the human therapist's direction. How could those savvy med school grads not somehow discern this emerging disruption and transformation of the mental health realm? It seems quite a vexing mystery. These are smart students who have painstakingly made their way in a herculean fashion through modern med school. Choosing their next step is bound to be something they have noodled on throughout the excruciating medical school experience. The odds of making a haphazard choice are exceedingly low. What gives? Eyes Wide Open Is The Case First, let's assume that they are generally cognizant of the looming takeover of AI in the mental health realm. I say this because some pundits would contend that they are unaware of this possibility. These newbie grads simply don't realize that AI is rapidly emerging in this domain. My interactions with med school students suggest otherwise. These are digital natives who embrace the latest online tools. Many of them leaned into generative AI and LLMs during their schooling, often doing so on their own since the university was either silent on the matter or was agonizingly trying to figure out what role AI should have in the medical education arena. Via grit and keen interest, these battle-hardened med school students have ventured into the AI side of things. The gist is that few of these grads seem to have their heads in the sand. Most tend to see clearly that AI is coming. They are not choosing a path that will catch them completely off-guard, which is a base assumption that some are saying is going to happen to them. Belief In The Human-To-Human Sanctity One logical basis for going the psychiatry direction is that they ardently believe in the sanctity of human-to-human interaction. People who use AI for their mental health pursuits will, at times, realize that it isn't the same as a truly human-to-human experience. They will rely partially on human-to-AI assistance but ultimately seek human pairing too. It isn't a one-size-fits-all solution. Instead, AI becomes part of a larger picture that still includes human therapists. I've coined the new arrangement of therapist-AI-patient as the triad, which is gradually supplanting the classic duo or dyad of therapist-patient; see my discussion at the link here. Med school grads readily grasp this evolving relationship. For them, adding AI into the mix provides no fear. They astutely perceive that AI has its place, as does the human-to-human element. Embracing AI Rather Than Sidelining It Another facet is that these med school grads are eager to embrace AI. Whereas some longstanding members of the profession are resistant to AI and insist that AI must be kept out of the loop, these eye-opening grads realize that there is little sense in tilting at windmills. You might as well accept that AI is going to be an integral part of the profession. It is career-limiting to try and simply wish that AI goes away. Advances in AI are going to radically expand how AI gets immersed in mental health advisement. This is a train that isn't going to stop. Recent grads aim to be on the train, rather than getting rolled over by the train. AI is already in the loop and will increasingly be in the loop. Period, end of story. Shaping AI In Mental Health This embracing of AI goes a step further. Some grads are hopeful of being pioneers in intertwining AI into the field of psychiatry. When the transformation of a domain is underway, great opportunities arise. For my recounting of the history of AI and the field of psychology as intertwined cousins, see the link here. Think of it this way. The golden age of therapist-AI-patient is going to inevitably emerge. We aren't there yet. If you want to make a difference, a big difference, the timing of doing so is almost ideal. AI will allow a reach of mental health guidance at a massive scale. We already know that, for example, ChatGPT by OpenAI already garners around 400 million weekly active users, and some proportion of those are indubitably leveraging AI for mental health advice (see my effort to calculate the population-level magnitude, at the link here). Now is the early stage of enormous change afoot, and these grads are going to be part of that new wave. In a given standalone career, there are only so many patients or clients that a solo therapist can help out. The number of patients is capped by the number of hours that a psychiatrist can muster on a weekly and annual basis. Time is precious. But by being instrumental in shaping AI for mental health, they can have a demonstrable impact on an immense scale. Their energy and enlightenment on how AI should undertake mental health guidance provides a strident possibility for establishing a legacy that will last their lifetimes and beyond. Money Making Too Let's revisit the earlier noted factor of an expanding demand for mental health advisement and the somewhat materialistic assumption that pursuing psychiatry will therefore ensure a long-lived livelihood for those in the psychiatry field on a demand/supply basis. Again, there's nothing wrong with picking a career path that provides sufficient monetary fulfillment along with professional fulfillment. Some of these grads are undoubtedly eyeing how they can avidly pursue an AI startup that weaves together the latest in AI and the AI-driven delivery of mental health advice. There are plenty of big bucks flowing from VCs and healthcare providers to this niche. Might as well jump into that lucrative pond. In essence, their forte provides insights into psychology and human mental health guidance, and they are primed and ready to aid in devising AI that can do a bang-up job, similarly. One angle is to pair up with erstwhile heads-down AI developers to figure out ways to get AI to do this. Especially getting the AI to act safely and suitably. You see, there are many weaknesses and concerns about how AI can actually undercut mental health by giving out lousy advice or even endangering guidance -- these are yet to be resolved concerns. See my analysis at the link here. Disruption As Challenge And Opportunity For those grads that might be behind the eight ball, perhaps they aren't foreseeing the upcoming disruption that is going to undeniably occur. If they want to have a conventional mental health practice, good luck with that. Ignoring AI won't make AI go away. At some juncture, their non-AI imbued practice will have to contend with AI or close its doors. I would wager that most of these grads are wise to the advent of AI in their profession. They aren't sure what way AI is going to go. They aren't quite sure what their role will be in the upcoming transformation of how mental health therapy takes place. They are certainly sure that they have the right stuff that will ensure they are primed to take on new ways of doing business. The final word for now goes to Carl Jung and his legendary remark: 'Who looks outside, dreams; who looks inside, awakes.' That's exactly what those new grads pursuing psychiatry already know to be true, particularly in an AI-based future.